Sara Yankelev

Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers

Mark Benvenuto, David P. Benziger, Sara Yankelev et al. · Antimicrobial Agents and Chemotherapy · 2006 · 320 citations · Full text

Antimicrobial Susceptibility, Health Sciences, Medicine +14

Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam plus Metronidazole Compared with Meropenem in Adult Patients with Complicated Intra-Abdominal Infections

Christopher Lucasti, Ellie Hershberger, Benjamin Miller et al. · Antimicrobial Agents and Chemotherapy · 2014 · 107 citations · Full text

Randomized Controlled Trial of the Safety and Efficacy of Daptomycin versus Standard-of-Care Therapy for Management of Patients with Osteomyelitis Associated with Prosthetic Devices Undergoing Two-Stage Revision Arthroplasty

Ivor Byren, Shruta Rege, Ed Campanaro et al. · Antimicrobial Agents and Chemotherapy · 2012 · 91 citations · Full text

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

John Mohr, Lawrence V. Friedrich, Sara Yankelev et al. · International Journal of Antimicrobial Agents · 2009 · 65 citations

Antimicrobial Susceptibility, Antimicrobial Stewardship, Antibiotics +7

Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.

David P. Benziger, Peter Pertel, Julie Donovan et al. · PubMed · 2011 · 18 citations